Canopy Growth Buys Out Cannabis Research Joint Venture
The acquisition streak in the marijuana industry just got a bit longer. Canadian producer Canopy Growth (NYSE: CGC) announced it has reached a deal to fully acquire a research joint venture it co-founded in 2018.
That business is Beckley Canopy Therapeutics, described by Canopy Growth as an entity designed "to research and develop clinically validated cannabis-based medicines, with a strong focus on intellectual property protection." Canopy Growth disclosed neither the terms nor the price of its acquisition.
Image source: Getty Images.
Source Fool.com
